The healthcare giant just took a major step that could reshape its MedTech business and boost its dividend track record.
Johnson & Johnson (NYSE:JNJ) Q4 2025 Earnings Call Transcript January 21, 2026 Johnson & Johnson reports earnings inline with ...
Johnson & Johnson ( JNJ) Q4 2025 Earnings Call January 21, 2026 8:30 AM EST Good morning, and welcome to Johnson & Johnson's Fourth Quarter 2025 Earnings Conference Call. [Operator Instructions] This ...
A chain of immune reactions in the gut—driven by a key signaling protein and a surge of white blood cells from the bone ...
2don MSN
New CT imaging oral contrast agent improves visualization of bowel anatomy, clinical trial data show
In a new pilot feasibility study, researchers from Mayo Clinic, the University of Washington School of Medicine, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results